INAF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Indofarma Tbk PT

Watchlist Manager

Watchlist

Price: 126 IDR Market Closed

Market Cap: Rp390.5B

	Indofarma Tbk PT IDX:INAF	ID
M	Mediobanca Banca di Credito Finanziario SpA DUS:ME9	IT
F	Fu Burg Industrial Co Ltd TPEX:8929	TW
	Kurabo Industries Ltd TSE:3106	JP
	Black Bird Biotech Inc OTC:BBBT	US
G	G Medical Innovations Holdings Ltd OTC:GMVDF	IL
O	Obsidian Energy Ltd F:P13A	CA
L	Lyft Inc SWB:LY0	US
N	Northrop Grumman Corp XMUN:NTH	US
E	Encompass Health Corp SWB:HSOA	US
	WEG SA BOVESPA:WEGE3	BR
	Coppermoly Ltd ASX:COY	AU
	Grid Battery Metals Inc XTSX:CELL	CA
	Tower Resources PLC LSE:TRP	UK
	Tenaris SA BMV:TS	LU
	Widodo Makmur Unggas Tbk PT IDX:WMUU	ID

Profitability Summary

Indofarma Tbk PT's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-1%

Negative 3Y Average Gross Margin

-29%

Gross Margin is Increasing

-26% > -1%

Negative Operating Margin

Negative 3Y Average Operating Margin

-119%

Operating Margin is Increasing

-74% > 0%

Negative Net Margin

-41%

Negative 3Y Average Net Margin

-142%

Net Margin is Increasing

-64% > -41%

Negative Free Cash Flow Margin

-129%

Negative 3Y Average Free Cash Flow Margin

-57%

Declining Free Cash Flow Margin

-36% > -129%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-84%

ROIC is Increasing

-41% > 0%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.